Cargando…

A target‐mediated drug disposition population pharmacokinetic model of GC1118, a novel anti‐EGFR antibody, in patients with solid tumors

ABSTRACT: GC1118 is a monoclonal antibody for epidermal growth factor receptor (EGFR) that is currently under clinical development to treat patients with solid tumors. In this study, the pharmacokinetics (PKs) of GC1118 were modeled in solid tumor patients who received a 2‐h intravenous infusion of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chung, Tae Kyu, Lee, Hyun A., Park, Sang‐In, Oh, Do‐Youn, Lee, Keun‐Wook, Kim, Jin Won, Kim, Jee Hyun, Woo, Ahmi, Lee, Su Jin, Bang, Yung‐Jue, Lee, Howard
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8212746/ https://www.ncbi.nlm.nih.gov/pubmed/33382918 http://dx.doi.org/10.1111/cts.12963

Ejemplares similares

A First‐in‐Human Phase I Study of GC1118, a Novel Anti‐Epidermal Growth Factor Receptor Antibody, in Patients with Advanced Solid Tumors
por: Oh, Do‐Youn, et al.
Publicado: (2019)

A multicenter, phase II trial of GC1118, a novel anti‐EGFR antibody, for recurrent glioblastoma patients with EGFR amplification
por: Choi, Seung Won, et al.
Publicado: (2023)

Therapeutic Efficacy of GC1118, a Novel Anti-EGFR Antibody, against Glioblastoma with High EGFR Amplification in Patient-Derived Xenografts
por: Lee, Kyoungmin, et al.
Publicado: (2020)

Promising Therapeutic Efficacy of GC1118, an Anti-EGFR Antibody, against KRAS Mutation-Driven Colorectal Cancer Patient-Derived Xenografts
por: Lee, Hye Won, et al.
Publicado: (2019)

Phase I Pharmacokinetic Study of Nivolumab in Korean Patients with Advanced Solid Tumors
por: Lee, Keun‐Wook, et al.
Publicado: (2017)

Phase I Study of CKD-516, a Novel Vascular Disrupting Agent, in Patients with Advanced Solid Tumors
por: Oh, Do-Youn, et al.
Publicado: (2016)

Individualized Tumor Response Testing for Prediction of Response to Paclitaxel and Cisplatin Chemotherapy in Patients with Advanced Gastric Cancer
por: Kim, Jee Hyun, et al.
Publicado: (2010)

TDP1 and TOP1 Modulation in Olaparib-Resistant Cancer Determines the Efficacy of Subsequent Chemotherapy
por: Kim, Jin Won, et al.
Publicado: (2020)

EGFR or HER2 inhibition modulates the tumor microenvironment by suppression of PD-L1 and cytokines release
por: Suh, Koung Jin, et al.
Publicado: (2017)

1118. Population Pharmacokinetics of Contezolid Acefosamil and Contezolid – Rationale for a Safe and Effective Loading Dose Regimen
por: Bulitta, Jürgen B, et al.
Publicado: (2021)

Phase 1 Studies of Poziotinib, an Irreversible Pan-HER Tyrosine Kinase Inhibitor in Patients with Advanced Solid Tumors
por: Kim, Tae Min, et al.
Publicado: (2018)

Weekly Paclitaxel and Trastuzumab as a First-Line Therapy in Patients with HER2-Overexpressing Metastatic Breast Cancer: Magnitude of HER2/neu Amplification as a Predictive Factor for Efficacy
por: Han, Hye-Suk, et al.
Publicado: (2009)

Lapatinib, a Dual EGFR and HER2 Tyrosine Kinase Inhibitor, Downregulates Thymidylate Synthase by Inhibiting the Nuclear Translocation of EGFR and HER2
por: Kim, Hwang-Phill, et al.
Publicado: (2009)

1118. Trends of Paediatric Prescribing for Common Infections in British Columbia
por: Saatchi, Ariana, et al.
Publicado: (2019)

Corrigendum: Three new species of the genus Biasticus Stål, 1867 (Insecta, Heteroptera, Reduviidae, Harpactorinae) from Central Highlands, Vietnam. ZooKeys 1118: 133–180. https://doi.org/10.3897/zookeys.1118.83156
por: Ha, Ngoc Linh, et al.
Publicado: (2022)

Prevalence and Risk Factors for Iron Deficiency Anemia in the Korean Population: Results of the Fifth Korea National Health and Nutrition Examination Survey
por: Lee, Jeong-Ok, et al.
Publicado: (2014)

Cocaine: analysis, pharmacokinetics, and metabolic disposition.
por: Jatlow, P.
Publicado: (1988)

Effect of Platinum-Based Chemotherapy on PD-L1 Expression on Tumor Cells in Non-small Cell Lung Cancer
por: Shin, Junghoon, et al.
Publicado: (2019)

Paclitaxel as third-line chemotherapy for small cell lung cancer failing both etoposide- and camptothecin-based chemotherapy
por: Kim, Se Hyun, et al.
Publicado: (2017)

Triple negativity and young age as prognostic factors in lymph node-negative invasive ductal carcinoma of 1 cm or less
por: Kwon, Ji Hyun, et al.
Publicado: (2010)

Drosophila melanogaster White Mutant w(1118) Undergo Retinal Degeneration
por: Ferreiro, María José, et al.
Publicado: (2018)

Rheological Impact of GBT1118 Cessation in a Sickle Mouse Model
por: Kanne, Celeste K., et al.
Publicado: (2021)

Improvement of hemolytic anemia with GBT1118 is renoprotective in transgenic sickle mice
por: Ren, Guohui, et al.
Publicado: (2022)

A pharmacokinetic comparison of two voriconazole formulations and the effect of CYP2C19 polymorphism on their pharmacokinetic profiles
por: Chung, Hyewon, et al.
Publicado: (2015)

A population-based outcomes study of patients with metastatic gastric cancer receiving second-line chemotherapy: A nationwide health insurance database study
por: Choi, In Sil, et al.
Publicado: (2018)

Advantages of Single-Molecule Real-Time Sequencing in High-GC Content Genomes
por: Shin, Seung Chul, et al.
Publicado: (2013)

Adjuvant Chemotherapy in Microsatellite Instability–High Gastric Cancer
por: Kim, Jin Won, et al.
Publicado: (2020)

R-MPV followed by high-dose chemotherapy with thiotepa-based and autologous stem cell transplantation for newly diagnosed primary central nervous system lymphoma: a single-center experience
por: Lee, Ji Yun, et al.
Publicado: (2021)

Screening study for genetic polymorphisms affecting pharmacokinetics of talniflumate
por: Jin, Li Hua, et al.
Publicado: (2017)

Cisplatin-Based Combination Chemotherapy for Advanced Hepatocellular Carcinoma: A Single Center Experience before the Sorafenib Era
por: Kim, Nae Yu, et al.
Publicado: (2010)

p21-Activated Kinase 4 (PAK4) as a Predictive Marker of Gemcitabine Sensitivity in Pancreatic Cancer Cell Lines
por: Moon, Sung-Ung, et al.
Publicado: (2015)

Tissue pharmacokinetics of DHP107, a novel lipid‐based oral formulation of paclitaxel, in mice and patients by positron emission tomography
por: Moon, Byung Seok, et al.
Publicado: (2021)

Acute pulmonary thromboembolism caused by factor V Leiden mutation in South Korea: A case report
por: Choe, Hun Jee, et al.
Publicado: (2019)

Disposition of Aerosols of Isothiazolinone-Biocides: BIT, MIT and OIT
por: Lee, Seungmi, et al.
Publicado: (2022)

Comparative steady-state pharmacokinetic study of an extended-release formulation of itopride and its immediate-release reference formulation in healthy volunteers
por: Yoon, Seonghae, et al.
Publicado: (2014)

Safety and Immunogenicity of an Egg-Cultivated Quadrivalent Inactivated Split-virion Influenza Vaccine (GC3110A) in Healthy Korean Children: a Randomized, Double-blinded, Active-controlled Phase III Study
por: Lee, Jin, et al.
Publicado: (2018)

Treatment patterns and outcomes in patients with metastatic gastric cancer receiving third-line chemotherapy: A population-based outcomes study
por: Choi, In Sil, et al.
Publicado: (2018)

A novel 11;18 translocation in a case of acute myeloid leukemia with maturation
por: Sandhya, Devi G., et al.
Publicado: (2012)

1118. Viral Species Richness and Composition in Young Children With Loose or Watery Stool in Ethiopia
por: Aiemjoy, Kristen, et al.
Publicado: (2018)

Licochalcone H Targets EGFR and AKT to Suppress the Growth of Oxaliplatin -Sensitive and -Resistant Colorectal Cancer Cells
por: Lee, Seung-On, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_94q6au5h081atp9r8fca6jckm9